These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 87878)

  • 1. Stimulation of prostacyclin by dipyridamole.
    Masotti G; Poggesi L; Galanti G; Neri Serneri GG
    Lancet; 1979 Jun; 1(8131):1412. PubMed ID: 87878
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of the stimulation of human venous prostacyclin synthesis by dipyridamole.
    Jackson CA; Greaves M; Preston FE
    Thromb Res; 1982 Sep; 27(5):563-73. PubMed ID: 6758183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipyridamole: a potent stimulator of prostacyclin (PGI2) biosynthesis.
    Blass KE; Block HU; Förster W; Pönicke K
    Br J Pharmacol; 1980 Jan; 68(1):71-3. PubMed ID: 6766769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole stimulates prostacyclin production in isolated rat aortic tissue.
    Van de Velde VJ; Bult H; Weisenberger H; Herman AG
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):327-8. PubMed ID: 7049101
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dose-dependent increase in prostacyclin synthesis from various vascular tissues by dipyridamole].
    Sinzinger H; Silberbauer K
    Wien Klin Wochenschr; 1982 Dec; 94(23):630-2. PubMed ID: 6762767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced prostacyclin production by dipyridamole in man.
    Neri Serneri GG; Masotti G; Poggesi L; Galanti G; Morettini A
    Eur J Clin Pharmacol; 1981; 21(1):9-15. PubMed ID: 7037426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dipyridamole on prostaglandin synthesis in human fibroblasts.
    Oetliker O; Lüthy C; Siegrist M; Odavic R
    Arzneimittelforschung; 1987 May; 37(5):566-8. PubMed ID: 3304302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stimulation of prostacyclin biosynthesis as a possible mechanism of action of dipyridamole (author's transl)].
    Mentz P; Pönicke K; Block HU; Giessler C; Blass KE; Bayer BL; Förster W
    Arzneimittelforschung; 1981; 31(12):2075-82. PubMed ID: 7037009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo injection of dipyridamole stimulates the synthesis of prostacyclin-like substances in human varicose veins.
    Fahr A; Langer R; Sziegoleit W; Beitz J; Krause P; Förster W
    Biomed Biochim Acta; 1984; 43(3):K6-8. PubMed ID: 6378192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
    Moncada S; Korbut R
    Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating prostacyclin.
    Lancet; 1978 Jul; 2(8079):21-2. PubMed ID: 78214
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostacyclin production augmented in the short term by nicotinic acid.
    Olsson AG; Carlson LA; Anggard E; Ciabattoni G
    Lancet; 1983 Sep; 2(8349):565-6. PubMed ID: 6136711
    [No Abstract]   [Full Text] [Related]  

  • 13. Rabbit lung microsomes: a rapid method for assaying simultaneously drug effects on thromboxane and prostacyclin synthesis.
    Ahnfelt-Rønne I; Arrigoni-Martelli E
    Agents Actions Suppl; 1979; (4):110-9. PubMed ID: 386739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonging prostacyclin production by nafazatrom or dipyridamole.
    Deckmyn H; Gresele P; Arnout J; Todisco A; Vermylen J
    Lancet; 1984 Aug; 2(8399):410-1. PubMed ID: 6147492
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased prostacyclin production from human veins by dipyridamole: an in vitro and ex vivo study.
    Costantini V; Talpacci A; Bastiano ML; Boschetti E; Cipolloni S; Bisacci R; Nenci GG
    Biomed Biochim Acta; 1990; 49(4):263-71. PubMed ID: 2119575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of myocardial prostaglandin biosynthesis and the influence of mechanical loading, endogenous mediators and cardiovascular drugs.
    Mentz P; Pawelski KE; Giessler C; Orlowa ZR; Geling NG; Taube C
    Biomed Biochim Acta; 1984; 43(8-9):S147-50. PubMed ID: 6393961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous epoprostenol on platelets and the cardiovascular system are not potentiated by dipyridamole.
    Pickles H; Fish A; Hassan S; Burke C; Warrington S; O'Grady J
    Clin Pharmacol Ther; 1983 Feb; 33(2):178-82. PubMed ID: 6337004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ingestion of dipyridamole reduces inhibitory effect of prostacyclin on human platelets.
    Di Minno G; Silver MJ; De Gaetano G
    Lancet; 1979 Sep; 2(8144):701-2. PubMed ID: 90798
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of various doses of acetylsalicylic acid in combination with dipyridamole on the balance between prostacyclin and thromboxane in human serum.
    Viinikka L; Ylikorkala O
    Br J Pharmacol; 1981 Feb; 72(2):299-303. PubMed ID: 7011467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.